GEN Exclusives

More »

GEN News Highlights

More »
Jun 11, 2007

deCODE Biostructures and InterMune Expand Screening Collaboration

  • deCODE biostructures initiated a third research project with InterMune. Under the research agreement, deCODE biostructures will conduct screening of its Fragments of Life™ library against an InterMune target. The research fee and milestone-based research collaboration will utilize deCODE's proprietary Fragments of Life technology and crystallographic methods to enable identification of new chemical intellectual property for small molecule inhibitors of InterMune's drug target.


Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?